Skip to main content

UPS Healthcare to Expand Cold Chain Capabilities in Europe with New Rome Facility

ROME, March 23, 2021 (GLOBE NEWSWIRE) — UPS (NYSE: UPS) today announced it is breaking ground on a new 40,000 square meter built-to-suit healthcare logistics facility in Rome, Italy. The state-of-the-art validated and GMP-compliant facility is scheduled to open July 2022, and will include multiple validated controlled temperature environments for healthcare products requiring -20C to -80C, 2C to 8C and 15C to 25C storage.

The facility will support pharmaceutical and medical device customers in Italy and will provide another direct link from Europe to UPS’s global network.

“We continue to expand our industry leading cold chain capabilities in the European market,” said Wes Wheeler, president of UPS Healthcare. “Our new facility in Rome will service the growth needs of our healthcare clients in a country that manufactures many of the world’s most important sterile pharmaceuticals.”

When combined with UPS Healthcare’s active temperature-controlled delivery services, this latest expansion highlights the company’s position as the provider of choice for end-to-end cold chain distribution and transportation.

“Our experience moving critical healthcare shipments, including COVID-19 vaccines, means that more of our clients are looking to us for solutions,” said Kate Gutmann, UPS chief sales and solutions officer, and senior vice president, UPS Global Healthcare. “We’re investing heavily in our global cold chain so we can continue to be a market leader in this space.”

This expansion, in addition to facility investments in Singapore, Shanghai, Australia and several key markets in the United States, is another step in implementing UPS Healthcare’s strategy. UPS’s recent investments also include: a new state-of-the-art GMP facility in Birmingham, United Kingdom; a new warehouse in the Czech Republic; cold chain expansion and a freezer farm in Roermond, The Netherlands; and a second central GMP facility near Warsaw, Poland.

The company now operates 125 GDP/GMP facilities in 34 countries around the world.

UPS Healthcare continues to provide extensive services addressing the full range of logistics needs from healthcare-licensed distribution space, to supply chain management, kitting, packaging and fulfillment of medical devices, labs and clinical trial specimens. The company’s global infrastructure, monitoring and tracking capabilities, and private data protection make UPS Healthcare a best-in-class supply chain expert that remains flexible, agile and responsive to myriad logistics demands.

About UPS Healthcare

UPS Healthcare delivers unparalleled logistics expertise to its customers around the world. UPS Healthcare has more than 10 million square feet of cGMP and GDP-compliant healthcare distribution space globally. UPS Healthcare services include inventory management, temperature-controlled packaging and shipping, storage and fulfillment of medical devices, labs and clinical trial logistics. UPS Healthcare’s global infrastructure, its UPS® Premier visibility service, its track and trace technology, and its global quality system are well-suited to meet today’s complex logistics demands for the pharmaceutical, medical device and laboratory diagnostic industries.

Contacts:
UPS Media Relations
404-828-7123
pr@ups.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.